SEARCH

SEARCH BY CITATION

References

  • 1
    Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002;97:7281.
  • 2
    Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K. Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc 2000;98:4952.
  • 3
    Sankaranarayanan R, Nene BM, Dinshaw K, Rajkumar R, Shastri S, Wesley R, et al. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica Mex 2003;45(Suppl. 3):S399407.
  • 4
    Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:34250.
  • 5
    Farzaneh F, Roberts S, Mandal D, Ollier B, Winters U, Kitchener HC, et al. The IL-10 -1082G polymorphism is associated with clearance of HPV infection. BJOG 2006;113:9614.
  • 6
    Winkelstein W. Smoking and cervical cancercurrent status: a review. Am J Epidemiol 1990;31:94558.
  • 7
    Simons AM, Múgica van Herckenrode C, Rodriguez JA, Maitland N, Anderson M, Phillips DH, et al. Demonstration of smoking related DNA damage in cervical epithelium and correlation with human papillomavirus type 16, using exfoliated cervical cells. Br J Cancer 1995;71:2469.
  • 8
    Hayden C, Pereira E, Rye P, Palmer L, Gibson N, Palenque M, et al. Mutation screening of interferon-gamma (IFNgamma) as a candidate gene for asthma. Clin Exp Allergy 1997;27:14126.
  • 9
    Schroder K, Hertzog PJ, Ravasi T, Hume DA. “Interferon-γ an overview of signals, mechanisms and functions”. J Leukoc Biol 2004;75:16389.
  • 10
    Horvath CM. The Jak-STAT pathway stimulated by interferon γ. Sci STKE 2004;260:tr8.
  • 11
    Gough DJ, Levy DE, Johnstone RW, Clarke CJ. IFN gamma signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev 2008;19:38394.
  • 12
    Oriss TB, McCarthy SA, Morel BF, Campana MA, Morel PA. Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1. J Immunol 1997;158:366672.
  • 13
    Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 2002;13:95109.
  • 14
    Tartour E, Gey A, Sastre-Garau X, Lombard Surin I, Mosseri V, Fridman WH. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 1998;90:28794.
  • 15
    Tso HW, Ip WK, Chong WP, Tam CM, Chiang AK, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 2005;6:35863.
  • 16
    Pravica V, Perry C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000;61:8636.
  • 17
    Schena FP, Cerullo G, Torres DD, Scolari F, Foramitti M, Amoroso A, et al. Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy:a family-based association study. Eur J Hum Genet 2006;14:48896.
  • 18
    Shepperd JH. FIGO staging of gynecologic cancers; cervical and vulva. Int J Gynecol Cancer 1995;5:319.
  • 19
    Miller SA, Dykes DD, Polesky HF. A salting procedure for extracting DNA from nucleated cells. Nucleic Acid Res 1998;16:1215.
  • 20
    Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 2002;13:95109.
  • 21
    Warlé MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003;9:17081.
  • 22
    Kashyap VK, Guha S, Sitalaximi T, Bindu GH, Hasnain SE, Trivedi R. Genetic structure of Indian populations based on fifteen autosomal microsatellite loci. BMC Genet 2006;7:28.
  • 23
    Linsingen RV, Bompeixe EP, Maestri CA, Carvalho NS, Bicalho MD. IFNG (+874 T/A) polymorphism and cervical intraepithelial neoplasia in Brazilian women. J Interferon Cytokine Res 2009;29:2858.
  • 24
    Tso HW, Ip WK, Chong WP, Tam CM, Chiang AKS, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 2005;6:35863.
  • 25
    Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, et al. Cytokine gene polymorphisms in patients infectedwith hepatitis B virus. Am J Gastroenterol 2003;98:14450.
    Direct Link:
  • 26
    Kerr JR, McCoy M, Burke B, Mattey DL, Pravica V, Hutchinson IV. Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection. J Clin Pathol 2003;56:7257.
  • 27
    Reichert S, Machulla HK, Klapproth J, Zimmermann U, Reichert Y, Gläser C, et al. Interferon-gamma and interleukin-12 gene polymorphisms and their relation to aggressive and chronic periodontitis and key periodontal pathogens. J Periodontol 2008;79:143443.
  • 28
    Anuradha B, Rakh SS, Ishaq M, Murthy KJ, Valluri VL. Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children. Pediatr Infect Dis J 2008;27:3259.
  • 29
    Govan VA, Carrara HRO, Sachs JA, Hoffman M, Stanczuk GA, Williamson A. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog 2003;2:3.
  • 30
    Hellberg D, Nilsson S, Haley NJ, Hoffman D, Wynder E. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 1988;158:9103.
  • 31
    Trimble CL, Genkinger JM, Burke AE, Hoffman SC, Helzlsouer KJ, Diener-West M, et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol 2005;105:17481.
  • 32
    Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study. IARC Multi-centre Cervical Cancer Study Group. Cancer Causes Control 2003;14:80514.